Filter Results:
(4,174)
Show Results For
- All HBS Web
(4,174)
- People (14)
- News (1,140)
- Research (2,080)
- Events (18)
- Multimedia (27)
- Faculty Publications (1,097)
Show Results For
- All HBS Web
(4,174)
- People (14)
- News (1,140)
- Research (2,080)
- Events (18)
- Multimedia (27)
- Faculty Publications (1,097)
- March 2013 (Revised August 2014)
- Case
Indonesia's OJK: Building Financial Stability
By: Lakshmi Iyer and David Lane
In 2013, a new financial services authority, the Otoritas Jasa Keuangan (OJK), took over responsibility for regulating capital markets and non-bank financial institutions in Indonesia. OJK was scheduled to take over bank regulation and supervision from the central... View Details
Keywords: Monetary Policy; Bank Regulation; Financial Market Regulation; Corruption; Bureaucracy; Central Bank Independence; Indonesia; Crime and Corruption; Central Banking; Ethics; Emerging Markets; Financial Markets; Corporate Governance; Financial Crisis; Financial Strategy; Financial Services Industry; Indonesia
Iyer, Lakshmi, and David Lane. "Indonesia's OJK: Building Financial Stability." Harvard Business School Case 713-003, March 2013. (Revised August 2014.)
- November 2020 (Revised September 2021)
- Case
BRAC in 2020
By: Tarun Khanna and Shreya Ramachandran
In 2020, the largest non-governmental organization in the world, BRAC, headquartered in Dhaka, Bangladesh, has some big problems to tackle. Its founder, Sir Fazle Hasan Abed, has left behind a challenge: take the 1981-founded organization from Bangladesh to every... View Details
Keywords: Social Enterprise; Education; Health; Social Issues; Poverty; Programs; Management; Growth and Development Strategy; Global Strategy; Health Industry; Health Industry; Bangladesh; South Asia
Khanna, Tarun, and Shreya Ramachandran. "BRAC in 2020." Harvard Business School Case 721-416, November 2020. (Revised September 2021.)
- 17 Mar 2011
- Research & Ideas
Harvard Business School Faculty Comment on Crisis in Japan
As Japan continues to come to grips with the devastating toll exacted by the earthquake within its borders, the aftershocks are just beginning to be felt within the global economy. Here, several Harvard Business School faculty members... View Details
Keywords: Re: Multiple Faculty
- 01 Jun 2020
- Working Paper Summaries
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
- December 2014 (Revised October 2017)
- Case
Social Business at Novartis: Arogya Parivar
By: Michael E. Porter, Mark R. Kramer and David Lane
Late in 2013, Novartis CEO Joseph Jimenez was considering whether or how to deepen the company's investment in Arogya Parivar, its profitable program that sold Novartis medicines in rural India while expanding access to medicine and health information to millions of... View Details
Keywords: Shared Value; India; Kenya; Vietnam; Novartis; Arogya Parivar; Social Business; Multinational Firms and Management; Competitive Advantage; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Viet Nam; Kenya; India
Porter, Michael E., Mark R. Kramer, and David Lane. "Social Business at Novartis: Arogya Parivar." Harvard Business School Case 715-411, December 2014. (Revised October 2017.)
- Video
Said Darwazah
Said Darwazah, Executive Chairman and CEO of Hikma Pharmaceuticals PLC, speaks about the importance of hiring local employees to help lead the company’s expansions into new markets, particularly in the context of political crises such as the Arab Spring or health... View Details
- Research Summary
Bodies at Risk: Chemicals Testing in the United States and Europe
This book project examines environmental regulation comparatively between the United States and Europe, with a focus on testing programs and controls on the manufacture of commodity and specialty chemicals. Findings thus far indicate that different relations among... View Details
- 2015
- Report
The Challenge of Shared Prosperity: Findings of Harvard Business School's 2015 Survey on U.S. Competitiveness
In the 2015 survey on U.S. competitiveness, HBS alumni weigh in on the current state and future trajectory of U.S. competitiveness as well as the structural strengths and weaknesses of the U.S. business environment. In addition, alumni delve deeper into two aspects of... View Details
Keywords: Competitiveness; U.S. Competitiveness; Shared Prosperity; Wealth; Competition; United States
Rivkin, Jan, Karen G. Mills, and Michael E. Porter. "The Challenge of Shared Prosperity: Findings of Harvard Business School's 2015 Survey on U.S. Competitiveness." Report, Harvard Business School, Boston, MA, September 2015 (With contributions from Michael I. Norton and Mitchell B. Weiss.)
- January 2021
- Case
Digital Transformation 2.0: CEO Elie Girard at Atos
By: Tsedal Neeley and James Barnett
Elie Girard has taken the helm as CEO of Atos—multinational IT giant—to lead the company into the next era of digital transformation. Noticing that customers’ digital needs were evolving to become even more specialized and global in scope, he made a bold first step as... View Details
Neeley, Tsedal, and James Barnett. "Digital Transformation 2.0: CEO Elie Girard at Atos." Harvard Business School Case 421-024, January 2021.
- Web
Faculty & Advisors - MBA
MS/MBA Biotechnology: Life Sciences Faculty & Advisors Faculty Amitabh Chandra, Ph.D. MS/MBA Program Faculty Co-Chair for MBA Henry and Allison McCance Professor of Business Administration at HBS, Ethel Zimmerman Winer Professor of Public... View Details
- 09 Jan 2007
- First Look
First Look: January 9, 2007
Venture Capital Investment Cycles: The Impact of Public Markets Authors:Paul Gompers, Anna Kovner, Josh Lerner, and David Scharfstein Publication:Journal of Financial Economics (forthcoming). (Earlier version distributed as National... View Details
Keywords: Martha Lagace
- 09 Apr 2013
- First Look
First Look: April 9
Cases & Course Materials Harvard Business School Case 612-016 Lowell General Physician Hospital Organization This case focuses on the Alternative Quality Contract (AQC), a novel payment program designed to incentivize providers to deliver less costly, high... View Details
Keywords: Sean Silverthorne
Gary P. Pisano
Gary Pisano is the Harry E. Figgie, Jr. Professor of Business Administration at the Harvard Business School where he has been on the faculty since 1988. From 2018-2023, Pisano was Harvard Business School’s Senior Associate Dean for Faculty Promotion and... View Details
- Article
Social Technology: An Interdisciplinary Approach to Improving Care for Older Adults
By: Arthur Kleinman, Hongtu Chen, Sue E. Levkoff, Ann Forsyth, David E. Bloom, Winnie Yip, Tarun Khanna, Conor J. Walsh, David Perry, Ellen W. Seely, Anne S. Kleinman, Yan Zhang, Yuan Wang, Jun Jing, Tianshu Pan, Ning An, Zhenggang Bai, Jiexiu Wang, Qing Liu and Fawwaz Habbal
Population aging is a defining demographic reality of our era. It is associated with an increase in the societal burden of delivering care to older adults with chronic conditions or frailty. How to integrate global population aging and technology development to help... View Details
Keywords: Health Care and Treatment; Age; Service Delivery; Information Technology; Collaborative Innovation and Invention
Kleinman, Arthur, Hongtu Chen, Sue E. Levkoff, Ann Forsyth, David E. Bloom, Winnie Yip, Tarun Khanna, Conor J. Walsh, David Perry, Ellen W. Seely, Anne S. Kleinman, Yan Zhang, Yuan Wang, Jun Jing, Tianshu Pan, Ning An, Zhenggang Bai, Jiexiu Wang, Qing Liu, and Fawwaz Habbal. "Social Technology: An Interdisciplinary Approach to Improving Care for Older Adults." Art. 729149. Frontiers in Public Health 9 (2021).
- August 2009 (Revised April 2012)
- Case
Genzyme's CSR Dilemma: How to Play its HAND
Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry
Bartlett, Christopher A., Tarun Khanna, and Prithwiraj Choudhury. "Genzyme's CSR Dilemma: How to Play its HAND." Harvard Business School Case 910-407, August 2009. (Revised April 2012.)
- March 2022
- Teaching Note
Supreme: Remaining Cool While Pursuing Growth
By: Jill Avery and Sandrine Crener
Teaching Note for HBS Case No. 522-006. Following VF Corporation’s acquisition of cult streetwear brand Supreme, consumers and industry pundits were nervous that becoming part of a large, public corporation would put an end to Supreme’s slow and careful growth... View Details
- 13 Jan 2021
- Blog Post
Staying Curious with the Harvard Innovation Labs Ahead of the 2021 Virtual President’s Innovation Challenge
What is the President’s Innovation Challenge (PIC)? The President’s Innovation Challenge (PIC) is a call to action for Harvard students and alumni pursuing ventures that push the boundaries of their fields. We have five total tracks and three student tracks in the... View Details
- 27 Sep 2016
- HBS Seminar
Catherine Tinsley, Georgetown University McDonough School of Business
- March–April 2024
- Article
How Companies Should Weigh in on a Controversy: A Better Approach to Stakeholder Management
By: David M. Bersoff, Sandra J. Sucher and Peter Tufano
Executives need guidance about managing their organizations’ engagement with societal issues—including hot-button topics such as gender, climate, and racial discrimination. Success in this realm does not mean avoiding public controversy or achieving unanimous support... View Details
Keywords: Values and Beliefs; Social Issues; Business and Stakeholder Relations; Judgments; Management Practices and Processes
Bersoff, David M., Sandra J. Sucher, and Peter Tufano. "How Companies Should Weigh in on a Controversy: A Better Approach to Stakeholder Management." Harvard Business Review 102, no. 2 (March–April 2024): 108–119.